NEW YORK – After acquiring Lucira Health in a bankruptcy auction in 2023, Pfizer has decided to shut down the business, a Pfizer spokesperson told GenomeWeb.
2h
Hosted on MSNFlags to fly at half-staff tomorrow in honor of Chuck HardwickNew Jersey Governor Phil Murphy has signed an executive order, ordering all U.S. and New Jersey Flags to fly at half-staff in ...
The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...
Novavax is starting to look like a vaccine development company again. And 2025 stands to be a big year for the local biotech.
We recently published a list of 10 Best Retirement Stocks to Buy According to Hedge Funds. In this article, we are going to ...
Pfizer Inc. (NYSE:PFE) is a leading global pharmaceutical company that researches, manufactures, and markets prescription ...
Novavax's net loss was $81 million for the quarter ended December 31, compared with a net loss of $178.3 million a year ago.
Revolving door is a VERY polite term for Patrizia Cavazzoni's moves. Then again, she has a 25-year history of picking Big Pharma over vulnerable patients. She'll fit right in with Scott Gottlieb.
Viatris forecast annual revenue and profit below Wall Street estimates on Thursday, two months after the U.S. health regulator restricted imports from one of the drugmaker's key plants in India.
Equities researchers at Zacks Research raised their Q3 2025 earnings estimates for Pfizer in a report issued on Monday, February 24th. Zacks Research analyst K. Shah now forecasts that the ...
Artificial intelligence improves process control and reduces the time required to produce key products such as the COVID-19 ...
Shares of Pfizer Inc. PFE slid 1.20% to $26.42 Wednesday, on what proved to be an all-around mixed trading session for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results